Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: A multicenter study

Cancer

Volumn 116, Issue 13, 2010, Pages 3170-3177

  Nakayama, Haruhiko ^a   Okumura, Sakae ^b   Daisaki, Hiromitsu ^c   Kato, Yasufumi ^a   Uehara, Hirofumi ^b   Adachi, Shuji ^d   Yoshimura, Masahiro ^d   Okada, Morihito ^e  

^a KANAGAWA CANCER CENTER   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d HYOGO CANCER CENTER   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Lung cancer; Malignancy grade; Positron emission tomography (PET) computed tomography (CT); Surgery

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PATIENT; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL RATE;

ADENOCARCINOMA; AGED; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954261528     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25244     Document Type: Article

References (21)

1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615-622.
2. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769-775. (Pubitemid 44415874)
3. Nakayama H, Yamada K, Saito H, et al. Sublobar resection for patients with peripheral small adenocarcinomas of the lung: surgical outcome is associated with features on computed tomographic imaging. Ann Thorac Surg. 2007;84:1675-1679. (Pubitemid 47588103)
4. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279-3287.
5. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histologic typing of lung and pleural tumours. In: World Health Organization International Histological Classification of Tumours. 3rd ed. Berlin: Springer; 1999:36.
6. Kuriyama K, Seto M, Kasugai T, et al. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma. AJR Am J Roentgenol. 1999;173:465-469. (Pubitemid 29347378)
7. Okada M, Nishio W, Sakamoto T, et al. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinoma. J Thorac Cardiovasc Surg. 2004;127:857-861. (Pubitemid 38316194)
8. Shimizu K, Yamada K, Saito H, et al. Surgically curable peripheral lung carcinoma. Correlation of thin-section CT findings with histologic prognostic factors and survival. Chest. 2005;127:871-878.
9. Dong B, Sato M, Sakurada A, et al. Computed tomographic images reflect the biologic behavior of small lung adenocarcinoma: they correlate with cell proliferation, microvascularization, cell adhesion, degradation of extracellular matrix, and K-ras mutation. J Thorac Cardiovasc Surg. 2005;130:733-739. (Pubitemid 41265712)
10. Suzuki K, Koike T, Shibata T, et al. Evaluation of radiologic diagnosis in peripheral clinical IA lung cancers. A prospective study for radiological diagnosis of peripheral early lung cancer (JCOG0201) [abstract]. J Clin Oncol. 2006;24:419. Abstract 7220.
11. Pieterman RM, van Putten JWG, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 2000;343:254-261. (Pubitemid 30490393)
12. Vansteenkiste J, Fisher BM, Dooms C, Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol. 2004;5:531-540. (Pubitemid 39194041)
13. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496-507. (Pubitemid 43200300)
14. Okada M, Tauchi S, Iwanaga K, et al. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. J Thorac Cardiovasc Surg. 2007;133:1448-1454. (Pubitemid 46802632)
15. Nomori H, Watanabe K, Ohtsuka T, et al. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1N0M0 lung adenocarcinoma. J Thorac Cardiovasc Surg. 2004;128:396-401. (Pubitemid 39194695)
16. Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885-895.
17. Westerterp M, Pruim J, Oyen W, et al. Quantification of FDG PET studies using standardized uptake values in multicenter trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. 2007;34:392-404.
18. Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res. 2000;6:3837-3844.
19. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75:2844-2852.
20. Boellaard R, Oyen WJG, Hoekstra CJ, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging. 2008;35:2320-2333.
21. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519-1527.